Current Opinion in Gastroenterology最新文献_第10页

In-hospital management of inflammatory bowel disease. 炎症性肠病的住院管理。

IF 2.6 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-26 DOI: 10.1097/MOG.0000000000000953

Jeffrey A Berinstein, Daniel Aintabi, Peter D R Higgins

{"title":"In-hospital management of inflammatory bowel disease.","authors":"Jeffrey A Berinstein, Daniel Aintabi, Peter D R Higgins","doi":"10.1097/MOG.0000000000000953","DOIUrl":"10.1097/MOG.0000000000000953","url":null,"abstract":"Purpose of review: The management of hospitalized patients with inflammatory bowel disease (IBD) is complex. Despite considerable therapeutic advancements in outpatient ulcerative colitis and Crohn's disease management, the in-hospital management continues to lag with suboptimal outcomes. The purpose of this review is to provide a brief overview of our approach to managing patients hospitalized with acute severe ulcerative colitis (ASUC) and Crohn's disease-related complications, followed by a summary of emerging evidence for new management approaches.Recent findings: ASUC has seen the emergence of well validated prognostic models for colectomy as well as the development of novel treatment strategies such as accelerated infliximab dosing, Janus kinase inhibitor therapy, and sequential therapy, yet the rate of colectomy for steroid-refractory ASUC has not meaningfully improved. Crohn's disease has seen the development of better diagnostic tools, early Crohn's disease-related complication stratification and identification, as well as better surgical techniques, yet the rates of hospitalization and development of Crohn's disease-related complications remain high.Summary: Significant progress has been made in the in-hospital IBD management; however, both the management of ASUC and hospitalized Crohn's disease remain a challenge with suboptimal outcomes. Critical knowledge gaps still exist, and dedicated studies in hospitalized patients with IBD are needed to address them.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"274-286"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9671695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Machine and deep learning in inflammatory bowel disease. 炎症性肠病的机器和深度学习。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-08 DOI: 10.1097/MOG.0000000000000945

Fatima Zulqarnain, S Fisher Rhoads, Sana Syed

{"title":"Machine and deep learning in inflammatory bowel disease.","authors":"Fatima Zulqarnain, S Fisher Rhoads, Sana Syed","doi":"10.1097/MOG.0000000000000945","DOIUrl":"10.1097/MOG.0000000000000945","url":null,"abstract":"Purpose of review: The Management of inflammatory bowel disease (IBD) has evolved with the introduction and widespread adoption of biologic agents; however, the advent of artificial intelligence technologies like machine learning and deep learning presents another watershed moment in IBD treatment. Interest in these methods in IBD research has increased over the past 10 years, and they offer a promising path to better clinical outcomes for IBD patients.Recent findings: Developing new tools to evaluate IBD and inform clinical management is challenging because of the expansive volume of data and requisite manual interpretation of data. Recently, machine and deep learning models have been used to streamline diagnosis and evaluation of IBD by automating review of data from several diagnostic modalities with high accuracy. These methods decrease the amount of time that clinicians spend manually reviewing data to formulate an assessment.Summary: Interest in machine and deep learning is increasing in medicine, and these methods are poised to revolutionize the way that we treat IBD. Here, we highlight the recent advances in using these technologies to evaluate IBD and discuss the ways that they can be leveraged to improve clinical outcomes.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"294-300"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9669372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lichen planus esophagitis. 扁平苔藓性食管炎。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-04-25 DOI: 10.1097/MOG.0000000000000936

Wojciech Blonski, Samuel Slone, John W Jacobs

{"title":"Lichen planus esophagitis.","authors":"Wojciech Blonski, Samuel Slone, John W Jacobs","doi":"10.1097/MOG.0000000000000936","DOIUrl":"10.1097/MOG.0000000000000936","url":null,"abstract":"Purpose of review: Dysphagia is one of the most common reasons for patients' visits to a gastroenterologist. Esophageal lichen planus (ELP) has historically been felt to be a rare disease, when in fact it is often misdiagnosed and unrecognized. Often first diagnosed as an unusual esophagitis, all gastroenterologists will see ELP in their practice, and need to be able to recognize this condition.Recent findings: Although there is still a relative paucity of data on this condition, this article will update the typical presenting symptoms, endoscopic findings, and ways to differentiate ELP from other inflammatory mucosal diseases. There is still no standardized treatment algorithm, but we will also present the most recent treatment approaches.Summary: It is critical that physicians maintain an increased awareness of ELP and have a high clinical suspicion in the appropriate patients. While management remains challenging, it is important to treat both the inflammatory and stricturing components of the disease. A multidisciplinary approach is also often required, utilizing dermatologists, gynecologists, and dentists who are familiar with managing patients with LP.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"308-314"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9663006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Modern approaches to treating Zenker's diverticulum. 治疗Zenker憩室的现代方法。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 DOI: 10.1097/MOG.0000000000000941

Lucas Fair, Marc A Ward

{"title":"Modern approaches to treating Zenker's diverticulum.","authors":"Lucas Fair, Marc A Ward","doi":"10.1097/MOG.0000000000000941","DOIUrl":"https://doi.org/10.1097/MOG.0000000000000941","url":null,"abstract":"Purpose of review: Zenker's diverticulum is the most common hypopharyngeal diverticulum. Patients with Zenker's diverticulum may require surgical treatment, which can be performed via an open surgical or endoscopic approach. A new endoscopic technique that is now being used for Zenker's diverticulum is Zenker Per Oral Endoscopic Myotomy (ZPOEM). ZPOEM has demonstrated promising results, and may have certain advantages over the other endoscopic treatments. The purpose of this review article is to evaluate the various surgical and endoscopic treatment options for Zenker's diverticulum, while specifically focusing on ZPOEM.Recent findings: Endoscopic approaches have become the first-line therapy for Zenker's diverticulum, replacing the traditional open approach, because of the less invasive nature of the endoscopic procedures, improved rates of morbidity, and quicker recovery times. Recent studies evaluating ZPOEM have demonstrated that it is technically feasible and highly efficacious. In addition, it has a low rate of clinical recurrence and adverse events. When compared with other endoscopic techniques for treating Zenker's diverticulum, ZPOEM appears to have improved outcomes.Summary: ZPOEM has been recently implemented in the algorithm of Zenker's diverticulum management. Further comparative and prospective studies focusing on long-term follow-up are still needed; however, ZPOEM appears to be an excellent option for patients suffering from Zenker's diverticulum.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"333-339"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9671720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The evaluation of liver abnormalities in inflammatory bowel disease patients. 炎症性肠病患者肝脏异常的评估。

IF 2.6 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-04-27 DOI: 10.1097/MOG.0000000000000942

Scott McHenry

{"title":"The evaluation of liver abnormalities in inflammatory bowel disease patients.","authors":"Scott McHenry","doi":"10.1097/MOG.0000000000000942","DOIUrl":"10.1097/MOG.0000000000000942","url":null,"abstract":"Purpose of review: Develop a clinical presentation-based approach for common liver abnormalities encountered by providers caring for patients with inflammatory bowel disease (IBD). Develop a treatment pathway for those with nonalcoholic fatty liver disease (NAFLD) arising in IBD. Discuss recent studies of prevalence, incidence, risk factors, and prognosis NAFLD in the IBD population.Recent findings: The work-up for liver abnormalities should be approached systematically in IBD patients, similar to the general population, while still appreciating the differing prevalence of underlying liver diagnoses. Although immune mediated liver diseases occur commonly in patients with IBD, NAFLD is still the most common liver disease in patients with IBD paralleling its expanding prevalence in the general population. IBD is also an independent risk factor for NAFLD, developing in many patients with lower degrees of adiposity. Furthermore, the more severe histologic subtype, nonalcoholic steatohepatitis, is both more common and difficult to treat considering the lower effectiveness of weight loss interventions.Summary: Having a standard approach to the most common liver disease presentations and care pathway for NAFLD will improve the quality of care provided and ease the medical decision making complexity for IBD patients. The early identification of these patients should prevent the development of irreversible complications like cirrhosis or hepatocellular carcinoma.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"287-293"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10366983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease. 高压氧治疗在炎症性肠病患者中的作用。

IF 2.6 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-30 DOI: 10.1097/MOG.0000000000000952

Harpreet Kaur, Gursimran Singh Kochhar, Parambir S Dulai

{"title":"Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease.","authors":"Harpreet Kaur, Gursimran Singh Kochhar, Parambir S Dulai","doi":"10.1097/MOG.0000000000000952","DOIUrl":"10.1097/MOG.0000000000000952","url":null,"abstract":"Purpose of review: Hypoxia is a known contributor to inflammation in inflammatory bowel diseases (IBD), and a growing interest has emerged in pharmacologically targeting hypoxia response pathways to treat IBD. The most basic form of treatment for hypoxia is delivering higher amounts of oxygen to the intestinal mucosa. In this review, we summarize the evidence in support of hyperbaric oxygen therapy (HBOT), a mechanism to deliver high amounts of oxygen to tissue, for treating IBD.Recent findings: Two phase 2 clinical trials in hospitalized ulcerative colitis patients suffering from moderate-to-severe flares have demonstrated that HBOT improves responsiveness to steroids and avoidance of rescue medical and surgical therapy. Outpatient cohort studies in perianal fistulizing Crohn's disease and fistulizing complications of the pouch have demonstrated improved healing, particularly for complex fistulae. Several systematic reviews have now been completed, and HBOT has been observed to be well tolerated with low rates of adverse events.Summary: HBOT may be considered as an adjunctive treatment for hospitalized ulcerative colitis flares and Crohn's disease-related fistulae. Higher quality trials are needed to confirm efficacy.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"263-267"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9698914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Editorial introductions. 编辑介绍。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 DOI: 10.1097/MOG.0000000000000947

引用次数: 0

Clostridium difficile in inflammatory bowel disease. 炎症性肠病中的艰难梭菌。

IF 2.6 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-15 DOI: 10.1097/MOG.0000000000000949

Tamara Alhobayb, Matthew A Ciorba

{"title":"Clostridium difficile in inflammatory bowel disease.","authors":"Tamara Alhobayb, Matthew A Ciorba","doi":"10.1097/MOG.0000000000000949","DOIUrl":"10.1097/MOG.0000000000000949","url":null,"abstract":"Purpose of review: The chronic inflammatory bowel diseases (IBD), Crohn's disease, and ulcerative colitis, are associated with an increased risk of symptomatic Clostridium difficile infection (CDI). CDI may also masquerade as an IBD flare and complicate IBD management. This review provides a comprehensive overview of the epidemiology, diagnosis, and treatment of CDI in IBD patients.Recent findings: CDI remains common in IBD with complications including flares in disease activity, recurrent CDI episodes, and prolonged hospital stays. Newer IBD therapeutics including vedolizumab, ustekinumab, and tofacitinib are less likely to cause severe CDI. A high index of suspicion, rapid testing via a two-step method, and prompt treatment with vancomycin or fidaxomicin are paramount to managing CDI in IBD patients. Strategies to prevent recurrent CDI (rCDI) include the monoclonal antibody bezlotoxumab as well as fecal microbiota transplantation (FMT). FMT has a robust profile of safety and effectiveness in preventing rCDI in adults and children.Summary: Clinicians must remain vigilant in the prompt diagnosis and treatment of CDI in IBD patients. Corticosteroids, unnecessary antibiotics, and ongoing colonic inflammatory disease are modifiable risk factors. Improved infection control measures, newer IBD medications, and using effective CDI treatments will facilitate a reduced burden of severe CDI and complications for IBD patients.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"257-262"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9663561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Inflammatory bowel disease and cannabis: key counseling strategies. 炎症性肠病与大麻：关键咨询策略。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-03 DOI: 10.1097/MOG.0000000000000946

Jakob Saidman, Samantha Rubin, Arun Swaminath

{"title":"Inflammatory bowel disease and cannabis: key counseling strategies.","authors":"Jakob Saidman, Samantha Rubin, Arun Swaminath","doi":"10.1097/MOG.0000000000000946","DOIUrl":"10.1097/MOG.0000000000000946","url":null,"abstract":"Purpose of review: Cannabis use is becoming more frequent in patients with inflammatory bowel disease (IBD). Because of the increased usage, gastroenterologists need to be cognizant of the benefits and risks associated with cannabis use in the IBD-patient population.Recent findings: Recent studies have attempted to determine whether cannabis can improve biomarkers or endoscopic findings of inflammation in patients with IBD, but the results have been inconclusive. However, cannabis has been shown to have an impact on the symptoms and quality of life of individuals with IBD. Despite these benefits, the use of cannabis in IBD is not without risks, including the potential for systemic illness, toxin ingestion and significant drug interactions.Summary: In this review article, we use a case-based approach to discuss the critical clinical data that informs us of the benefits and risks of cannabis use in IBD. The endocannabinoid system plays a crucial role in regulating various physiological functions including the gastrointestinal tract. Studies have investigated the impact of cannabis on various medical conditions, including IBD. Clinicians must be aware of the most recent data to properly educate their patients on the benefits and risks of its use.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"301-307"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9669371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The status of endoscopic therapies for gastroesophageal reflux disease. 胃食管反流病的内镜治疗现状。

IF 2.5 3区医学

Current Opinion in Gastroenterology Pub Date : 2023-07-01 Epub Date: 2023-05-26 DOI: 10.1097/MOG.0000000000000944

Jennifer M Kolb, Kenneth J Chang

{"title":"The status of endoscopic therapies for gastroesophageal reflux disease.","authors":"Jennifer M Kolb, Kenneth J Chang","doi":"10.1097/MOG.0000000000000944","DOIUrl":"10.1097/MOG.0000000000000944","url":null,"abstract":"Purpose of review: Gastroesophageal reflux disease (GERD) is exceedingly common and can significantly impact quality of life through heartburn, troublesome regurgitation, or atypical symptoms. The initial approach is conservative lifestyle changes followed by medications with escalation to antireflux surgery as needed. Endoscopic therapy may represent a bridge between pharmacotherapy and surgery and represents an appropriate option for select individuals.Recent findings: Appropriate patient selection for endoscopic antireflux therapies is critical to the success of the intervention. Candidates for endoscopic treatment with trans-oral incisionless fundoplication (TIF) include those with a small (<2 cm) or no hiatal hernia and a Hill valve grade 1 or 2. Transoral incisionless fundoplication with concomitant hiatal hernia repair (cTIF) is a safe and effective option that addresses both the crural diaphragm and gastroesophageal flap valve (GEFV).Summary: Endoscopic interventions for GERD continue to evolve and are not all created equal. Given our current understanding of the mechanisms of GERD, the TIF procedure stands out in its ability to re-create the optimal GEFV. In those patients with altered anatomy, endoscopic approaches may offer at least partial benefit.","PeriodicalId":50607,"journal":{"name":"Current Opinion in Gastroenterology","volume":"39 4","pages":"326-332"},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9671696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0